On January 7, the Microbicide Trials Network (MTN) made the welcome announcement that it had added the first clinical trial of a microbicide for women living with HIV to its research portfolio.
In this week's sexual health round up: we have hit an expected but dreaded milestone with the first document cases of cephalosporin-resistant gonorrhea in North America; a major porn producer sues the city of Los Angeles to stop the enforcement of an on-set condom requirement; and study shows that an age-old herb might work just as well as modern prescription drugs for erectile issues.
In what could be a major breakthrough, researchers developed a test—similar to the Pap Test—that was able to find ovarian and uterine cancer cells in cervical fluid. Though it is years from the market it has the potential to save thousands of lives.
The Texas Health and Human Services Commission has said that it will have absolutely no trouble managing the number of clients in its new Texas Women's Health Program, according to the department's own survey. According to everyone else? Not so much.
